Correlation Between Organogenesis Holdings and Redhill Biopharma
Can any of the company-specific risk be diversified away by investing in both Organogenesis Holdings and Redhill Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Organogenesis Holdings and Redhill Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Organogenesis Holdings and Redhill Biopharma, you can compare the effects of market volatilities on Organogenesis Holdings and Redhill Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Organogenesis Holdings with a short position of Redhill Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Organogenesis Holdings and Redhill Biopharma.
Diversification Opportunities for Organogenesis Holdings and Redhill Biopharma
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Organogenesis and Redhill is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Organogenesis Holdings and Redhill Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Redhill Biopharma and Organogenesis Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Organogenesis Holdings are associated (or correlated) with Redhill Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Redhill Biopharma has no effect on the direction of Organogenesis Holdings i.e., Organogenesis Holdings and Redhill Biopharma go up and down completely randomly.
Pair Corralation between Organogenesis Holdings and Redhill Biopharma
Given the investment horizon of 90 days Organogenesis Holdings is expected to generate 1.01 times more return on investment than Redhill Biopharma. However, Organogenesis Holdings is 1.01 times more volatile than Redhill Biopharma. It trades about 0.26 of its potential returns per unit of risk. Redhill Biopharma is currently generating about -0.08 per unit of risk. If you would invest 303.00 in Organogenesis Holdings on November 3, 2024 and sell it today you would earn a total of 65.00 from holding Organogenesis Holdings or generate 21.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Organogenesis Holdings vs. Redhill Biopharma
Performance |
| Timeline |
| Organogenesis Holdings |
| Redhill Biopharma |
Organogenesis Holdings and Redhill Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Organogenesis Holdings and Redhill Biopharma
The main advantage of trading using opposite Organogenesis Holdings and Redhill Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Organogenesis Holdings position performs unexpectedly, Redhill Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Redhill Biopharma will offset losses from the drop in Redhill Biopharma's long position.| Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
| Redhill Biopharma vs. Organogenesis Holdings | Redhill Biopharma vs. Lifecore Biomedical | Redhill Biopharma vs. Collegium Pharmaceutical | Redhill Biopharma vs. Aquestive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |